Hatice Tuna Hörmet Öz

Hatice Tuna Hörmet Öz

Auto-generated profile, based on publicly available information

Hatice Tuna Hörmet Öz

Department of Medical Microbiology, Kayseri City Education and Research Hospital, Kayseri, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
MAMustafa Argun
Mustafa Argun
DİDoğan Bahadır İnan
Doğan Bahadır İnan
HÖHatice Tuna Hörmet Öz
Hatice Tuna Hörmet Öz
Mustafa Orhan DUYARMustafa Orhan DUYAR
Mustafa Orhan DUYAR
GBGöksu Başargan
Göksu Başargan
IÇIlhami Çelik
Ilhami Çelik
Objective: The reasons for a high prevalence of asymptomatic or mild coronavirus disease (COVID-19) and rare severe disease in children have been explained by non-immune and immune mechanisms. This study aimed to evaluate the immune system’s response to severe acute respiratory syndrome coronavirus 2 by investigating lymphocyte subsets. Materials and Methods: This study included 33 coronavirus disease positive children, of whom 12 had mild disease and 21 had an asymptomatic infection as the patient group and 26 ageand gender-matched healthy children as the control group. The demographic information, symptoms, physical examination findings, complete blood count, C-reactive protein (CRP), procalcitonin, and lymphocyte subsets were recorded in all subjects. Results: Leukocyte, lymphocyte, monocyte count, and hemoglobin levels of our pediatric coronavirus disease patients were similar to the control group. Neutrophil was lower in the coronavirus disease cases compared to the control group. CRP and procalcitonin levels of asymptomatic cases were similar to the control group. B cell count, CD8+ T cell count, and CD4/CD8 ratio (dividing the CD4 cell count by the CD8 cell count) ratio were similar in the patient and control groups. Natural killer, T cell, and CD4+ T cell counts were significantly higher in the whole patient group compared to the control group. Conclusion: One reason for mild severe acute respiratory syndrome coronavirus 2 infection in children may be an increase in some lymphocyte subsets such as natural killer cells, T cell, and CD4+ T cell. Understanding the answer to the question of why children develop more protective immunity to the virus could be an essential step for developing new treatments. Cite this article as: Argun M, Bahadır İnan D, Tuna Hörmet Öz H, et al. Lymphocyte subsets in mild COVID-19 pediatric patients. Turk Arch Pediatr. 2022;57(2):210-215.

11 March 2023 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
EEEsma Eryilmaz-Eren
Esma Eryilmaz-Eren
MKMustafa Köker
Mustafa Köker
AUAysegul Ulu-Kilic
Aysegul Ulu-Kilic
HHHatice Tuna Hurmet-Oz
Hatice Tuna Hurmet-Oz
YAYasemin Ay Altintop
Yasemin Ay Altintop
ICIlhami Celik
Ilhami Celik
Objective: Most patients with coronavirus disease (COVID-19) have abnormalities of lymphocyte subsets. This study aimed to determine the distribution of lymphocytes in patients with various severity levels of COVID-19 and to describe the relationship between the CD4+ T helper and prognosis. Materials and Methods: Adult (>18 years old) patients with COVID-19 who followed up in a tertiary hospital were included in the study prospectively. Demographic and clinical characteristics of the patients were obtained from the hospital records. Peripheral flow cytometry was studied in patients with different severity of COVID-19 and different prognoses. Next, we analyzed the characteristics and predictive values of lymphocyte subsets in COVID-19 patients. Results: Totally 86 patients were included in the study, of which 21 (24.4%) had asymptomatic, 23 (26.7%) had mild/moderate, and 42 (48.8%) had severe/critical COVID-19. Severe/critical patients had lower lymphocyte levels and older age than asymptomatic patients ( p <0.001 and p <0.001, respectively). We determined that decreased CD4+ T cell ratio ( p <0.001) and CD4+/CD8+ ratio ( p <0.001) were indicative of the severity of the disease. CD4+ T cell ratio on admission (odds ratio [OR]=0.858; p =0.033), day seven CD4+ T cell ratio (OR=0.840; p =0.029), and C-reactive protein (CRP) levels (OR=1.014; p =0.043) were prognostic factors for mortality. According to receiver operating characteristics (ROC) curve analysis, the area under the curve was greater than 0.9 for decreased CD4+ T cell ratio on admission and the seventh day. Conclusion: A low CD4+ T helper ratio predicts a poor prognosis. In combination with CRP, it can be used in clinical follow-up. Keywords: CD4 + T helper, lymphocyte subset, severe COVID-19